×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MYNZ – mainz biomed n.v. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MYNZ
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/1
08:01 am
mynz
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
High
Report
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
3/27
09:01 am
mynz
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
High
Report
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
3/13
08:01 am
mynz
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Medium
Report
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
3/3
08:01 am
mynz
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
Medium
Report
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
2/20
08:01 am
mynz
Mainz Biomed Expands into Switzerland with labor team w
Low
Report
Mainz Biomed Expands into Switzerland with labor team w
2/14
08:16 am
mynz
Mainz Biomed (NASDAQ: MYNZ) is now covered by analysts at Maxim Group. They set a "buy" rating and a $14.00 price target on the stock.
Medium
Report
Mainz Biomed (NASDAQ: MYNZ) is now covered by analysts at Maxim Group. They set a "buy" rating and a $14.00 price target on the stock.
2/11
08:01 am
mynz
Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month
High
Report
Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month
1/27
08:01 am
mynz
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
Medium
Report
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
4/1
08:01 am
mynz
Form 6-K MAINZ BIOMED N.V. For: Apr 01
High
Report
Form 6-K MAINZ BIOMED N.V. For: Apr 01
3/31
05:23 pm
mynz
Form 20-F MAINZ BIOMED N.V. For: Dec 31
High
Report
Form 20-F MAINZ BIOMED N.V. For: Dec 31
3/13
08:30 am
mynz
Form 6-K MAINZ BIOMED N.V. For: Mar 13
Low
Report
Form 6-K MAINZ BIOMED N.V. For: Mar 13
2/14
04:49 pm
mynz
Form SCHEDULE 13G MAINZ BIOMED N.V. Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SCHEDULE 13G MAINZ BIOMED N.V. Filed by: ARMISTICE CAPITAL, LLC
1/27
08:00 am
mynz
Form 6-K MAINZ BIOMED N.V. For: Jan 27
Medium
Report
Form 6-K MAINZ BIOMED N.V. For: Jan 27
1/14
05:15 pm
mynz
Form 6-K MAINZ BIOMED N.V. For: Jan 14
Medium
Report
Form 6-K MAINZ BIOMED N.V. For: Jan 14
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: